These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20077591)

  • 21. Cardiac resynchronization therapy for mild congestive heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2010 Apr; 24(8):1-5. PubMed ID: 20575185
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac resynchronization therapy].
    Karczmarewicz S
    Kardiol Pol; 2003 Jul; 59(7):83-5. PubMed ID: 14560359
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac resynchronization therapy--who benefits? Separating myths from facts.
    Deshpande S; Tol S; Lokhandwala Y
    Indian Heart J; 2007; 59(1 Suppl A):A57-62. PubMed ID: 19104133
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--For].
    Klein HU
    Dtsch Med Wochenschr; 2006 Apr; 131(14):772. PubMed ID: 16596499
    [No Abstract]   [Full Text] [Related]  

  • 26. Device therapy for the management of advanced heart failure.
    Krishnamani R; DeNofrio D
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):573-80. PubMed ID: 15225116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac resynchronization therapy for heart failure.
    Abraham WT; Hayes DL
    Circulation; 2003 Nov; 108(21):2596-603. PubMed ID: 14638522
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cardiac resynchronization therapy: are all questions answered?].
    Auricchio A
    Herzschrittmacherther Elektrophysiol; 2005 Mar; 16(1):1-2. PubMed ID: 15824869
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
    Wedekind H; Möller K
    Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization as therapy for congestive cardiac failure in children dependent on chronic cardiac pacing.
    van Beek E; Backx A; Singh S
    Cardiol Young; 2006 Apr; 16(2):187-9. PubMed ID: 16553984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
    Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac resynchronization therapy in chronic heart failure].
    Sticherling C
    Praxis (Bern 1994); 2007 Mar; 96(11):421-2. PubMed ID: 17405535
    [No Abstract]   [Full Text] [Related]  

  • 35. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy for heart failure: has the time come?
    Yancy CW; Filardo G
    Circulation; 2009 Feb; 119(7):916-8. PubMed ID: 19237670
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance.
    Barnett D; Phillips S; Longson C
    Heart; 2007 Sep; 93(9):1134-5. PubMed ID: 17699177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dose response for cardiac resynchronization therapy?
    Faddis MN
    J Am Coll Cardiol; 2009 Jan; 53(4):361-2. PubMed ID: 19161887
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure--Against].
    Ertl G; Bauer W
    Dtsch Med Wochenschr; 2006 Apr; 131(14):773. PubMed ID: 16596500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.